AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra. AbbVie said it will pay up to about $2.2 billion for the drug GUBamy, which is currently in a Phase 1 ...
Xiaomi is rolling out the HyperOS 2.1 update to more smartphones and tablets. This update makes devices faster, improves battery life, and boosts performance. Xiaomi wants both flagship and mid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback